What does transplant clinical — revenue mean?

This metric represents the total gross revenue generated from the sale of products and services specifically within the Transplant Clinical business segment. It captures the financial performance of clinical solutions tailored for organ transplantation procedures and related patient care workflows. Monitoring this revenue stream provides insight into the company's market penetration and adoption rates within the specialized transplant medical community.

Strata Critical Medical (SRTA) Transplant Clinical — Revenue

Screener

Other product segments

Other Clinical

$9.95M—

Similar metrics at other companies

WWClinical Subscription Revenues — Revenue

$39.91M+38.3%

TEMClinical Order — Revenue

$239.3M+31.8%

SLPClinical Operations — Revenue

$277K-33.4%

MMSClinical Services — Revenue

$553.08M-1.3%

TMDXOcs Transplant Revenue — Revenue

$172.67M+21.0%

MLABClinical Genomics — Revenue

$10.29M-0.1%

Other financials

Income statement

See full

Revenue$67.4M+87.4%

Gross profit$14.1M+100%

Operating income-$3.0M+47.7%

Net income$2.2M+162%

EPS (diluted)$0.03+175%

Balance sheet

See full

Cash & equivalents$59.0M+65.3%

Total debt$4.5M-50.7%

Total equity$285.7M+30.0%

Total assets$327.6M+30.8%

Cash flow

See full

Operating cash flow$3.9M+1,679%

CapEx$5.2M+98.1%

Free cash flow-$1.3M+54.8%

Valuation

See full

Market cap$512.22M+40.4%

Enterprise value$457.7M—

P/E9.8×—

P/S2×—

Profitability

See full

Gross margin21.7%+1.3pp

Operating margin-7.8%-2.8pp

Net margin21%+13.6pp

FCF margin-22.4%+1,712pp

Returns & leverage

See full

Return on equity15.6%+10.0pp

Debt / equity0×0.0×

Current ratio5.9×-1.0×

Where this comes from

Reported directly by Strata Critical Medical in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Strata Critical Medical’s 10-Q, filed May 6, 2026.

Filed: May 6, 2026, 11:53 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001628280-26-031032

Line item	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
Logistics:
Logistics	$47,599	$35,948
Clinical:
Transplant Clinical	$9,839	—
Other Clinical	9,946	—
Total Clinical	$19,785	—
Total revenue	$67,384	$35,948

Item 1. Financial Statements

FAQ

What is Strata Critical Medical's transplant clinical — revenue?: Strata Critical Medical (SRTA) reported transplant clinical — revenue of $9.84M in Q1 2026.
What does transplant clinical — revenue mean?: This metric represents the total gross revenue generated from the sale of products and services specifically within the Transplant Clinical business segment. It captures the financial performance of clinical solutions tailored for organ transplantation procedures and related patient care workflows. Monitoring this revenue stream provides insight into the company's market penetration and adoption rates within the specialized transplant medical community.